Search by Drug Name or NDC
NDC 70000-0534-01 Leader 5 mg/g Details
Leader 5 mg/g
Leader is a TOPICAL GEL in the HUMAN OTC DRUG category. It is labeled and distributed by CARDINAL HEALTH, INC.. The primary component is LIDOCAINE HYDROCHLORIDE.
Product Information
NDC | 70000-0534 |
---|---|
Product ID | 70000-0534_ecb10671-a18a-69dc-e053-2995a90ab6d9 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Leader |
Proprietary Name Suffix | After Sun Cooling |
Non-Proprietary Name | Lidocaine Hydrochloride |
Product Type | HUMAN OTC DRUG |
Dosage Form | GEL |
Route | TOPICAL |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/g |
Substance Name | LIDOCAINE HYDROCHLORIDE |
Labeler Name | CARDINAL HEALTH, INC. |
Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH NOT FINAL |
Application Number | part348 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 70000-0534-01 (70000053401)
NDC Package Code | 70000-0534-1 |
---|---|
Billing NDC | 70000053401 |
Package | 226 g in 1 BOTTLE (70000-0534-1) |
Marketing Start Date | 2019-11-04 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 968b0056-3ab4-0a81-e053-2995a90ab69e Details
Uses
Stop use and ask a doctor if
Keep out of reach of children.
Directions
Inactive Ingredients
INGREDIENTS AND APPEARANCE
LEADER
AFTER SUN COOLING
lidocaine hydrochloride gel |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Labeler - CARDINAL HEALTH, INC. (063997360) |
Revised: 11/2022
Document Id: ecb10671-a18a-69dc-e053-2995a90ab6d9
Set id: 968b0056-3ab4-0a81-e053-2995a90ab69e
Version: 2
Effective Time: 20221104